Health Care Corporate Governance: Board Oversight of Compliance in Light of DOJ’s New Guidance
- October 18, 2024
Rob Gerberry, Senior Vice President and Chief Legal Officer, Summa Health, speaks with Michael Peregrine, Partner, McDermott Will & Emery, about the Department of Justice’s (DOJ’s) updated compliance program guidance and its implications for Board oversight of compliance. They discuss the DOJ’s updated Evaluation of Corporate Compliance Programs guidance, what Boards need to know, and specific considerations for the health care industry.
You must be logged in to access this content.